Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-14
2006-03-14
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S243000, C548S466000
Reexamination Certificate
active
07012088
ABSTRACT:
The present invention provides antibacterial agents of formula I described herein and intermediates for their preparation.
REFERENCES:
patent: 5164510 (1992-11-01), Brickner et al.
patent: 5225565 (1993-07-01), Brickner et al.
patent: 5529998 (1996-06-01), Habich et al.
patent: 5792765 (1998-08-01), Riedl et al.
patent: 5869659 (1999-02-01), Stolle et al.
patent: 6069160 (2000-05-01), Stolle et al.
patent: 0738726 (1996-04-01), None
patent: 0738726 (1996-04-01), None
patent: WO90/02744 (1990-03-01), None
patent: WO 95/07271 (1994-08-01), None
patent: WO 00/21960 (1998-10-01), None
patent: WO 00/29409 (1998-11-01), None
patent: WO 99/40094 (1999-01-01), None
patent: WO 99/64416 (1999-06-01), None
patent: WO 99/64417 (1999-06-01), None
patent: WO 01/47919 (2000-12-01), None
patent: WO 01/81350 (2001-04-01), None
patent: WO01/74812 (2001-10-01), None
patent: WO02/102785 (2002-12-01), None
patent: WO03/035073 (2003-05-01), None
patent: WO03/072253 (2003-09-01), None
Bioorganic and Medicinal Chemistry Letters, Dec. 1, 2003, vol. 13, No. 23, pp. 4235-4239(5).
Tetrahedron .Letter 1996, 37(44), 7937-7940.
Ashbrook Charles
Coppins Janet L.
McKane Joseph K.
Pharmacia & Upjohn Company
Yang Lucy X.
LandOfFree
Indolone oxazolidinones and derivatives thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indolone oxazolidinones and derivatives thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolone oxazolidinones and derivatives thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3533765